RxDoctor Payments Data

Richard Marvel, MD

Gynecology · Annapolis, MDNPI 1841286028

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $30,488 of the $39,810 with a category attached, or 76.6%. AbbVie accounts for 86.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $17,796 and has fallen 95.7% since, to $761 in 2025. Among gynecology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,810in general payments, 2019–2025

Across 216 payments — averaging $184.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$34K
  • Cook Incorporated$2K
  • Abbott$987
  • Sumitomo Pharma America, Inc.$592
  • Medtronic$561
  • Pfizer$339
  • plus $1K from 11 others

What the payments were for

  • Consulting fees$1,7174%
  • Speaking & faculty fees$30,48877%
  • Travel & lodging$3,94710%
  • Food & beverage$3,4889%
  • Education$1700%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,810 in reported general payments places this provider in the 95th percentile of 79 gynecology providers in Maryland.

See all gynecology providers in Maryland

Medicare billing

Part B allowed, 2024
$50,672
Medicare patients
153
Services billed
764

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol74$12,784
YuvafemEstradiol24$7,253
Clobetasol Propionate41$4,646
Pregabalin74$3,553
Gabapentin93$2,518
Duloxetine Hcl60$1,991
Amitriptyline Hcl46$1,106
Morphine Sulfate ErMorphine Sulfate29$572
Lidocaine Hcl ViscousLidocaine Hcl11$541
Nortriptyline Hcl19$327
Morphine Sulfate12$132

Paid to pharmacies, not to this prescriber.

Other gynecology in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →